Rhythm Pharmaceuticals Inc share price logo

Rhythm Pharmaceuticals Inc Share Price

NASDAQ: RYTM

Mid Cap

$96.01

-0.21

(-0.22%)

as on

Rhythm Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $94.39
    $97.05
    downward going graph

    1.69%

    Downside

    1.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $45.91
    $106.52
    downward going graph

    52.19%

    Downside

    10.95%

    Upside

    downward going graph

Rhythm Pharmaceuticals Inc share price movements today

Previous Close
$96.22
Open
$96.88
Volume
303.1K
Day's Low - High
$94.39 - $97.05
52 Week Low - High
$45.91 - $106.52

Rhythm Pharmaceuticals Inc Historical Returns

1 Month Return
-1.42 %
3 Month Return
+ 52.97 %
1 Year Return
+ 93.91 %
3 Year Return
+ 312.78 %
5 Year Return
0 %

Rhythm Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Rhythm Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4B

EPS (TTM)

-2.951

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.86

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-175.9M

Revenue (TTM)

156.3M

Profit Margin

-117.16%

Return On Equity TTM

12075100.00%

Rhythm Pharmaceuticals Inc Stock Valuation

Track how Rhythm Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Rhythm Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-10.86x)

September 15, 2025

Industry (10.13x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -10.86x

Rhythm Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rhythm Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.4BNA-10.86-117.16%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Rhythm Pharmaceuticals Inc Stock including INR - Dollar returns

The Rhythm Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Rhythm Pharmaceuticals Inc investment value today

Current value as on today

₹1,98,476

Returns

₹98,476

(+98.48%)

Returns from Rhythm Pharmaceuticals Inc Stock

₹93,491 (+93.49%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Rhythm Pharmaceuticals Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Rhythm Pharmaceuticals Inc. Average target price of $112.5

Rhythm Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Rhythm Pharmaceuticals Inc.

What analysts predicted

14.66%UPSIDE

Target Price

$112.5

Current Price

$96.01

Analyzed by

15 Analysts

Target

$112.50

Rhythm Pharmaceuticals Inc target price $112.5, a slight upside of 14.66% compared to current price of $96.01. According to 15 analysts rating.

Rhythm Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Rhythm Pharmaceuticals Inc Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Rhythm Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
11
19
22
24
25
29
33
41
32
48
Gross Profit
10
16
20
21
23
26
29
38
29
42
Operating Income
-52
-46
-43
-41
-139
-40
-43
-41
-47
-45
EBITDA
-48
-42
-40
-36
-135
-26
-38
-37
-43
-40
Interest Expense
3
3
3
4
4
4
5
5
5
5
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-52
-46
-43
-41
-141
-31
-43
-43
-49
-46
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-52
-46
-44
-41
-141
-32
-43
-43
-49
-46
Net Profit Margin
-454.96%
-242.98%
-196.25%
-171.80%
-544.43%
-110.95%
-131.25%
-103.50%
-151.35%
-96.14%

Rhythm Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
0
3
23
77
130
Gross Profit
-
0
0
0
0
0
2
21
68
116
Operating Income
-10
-25
-32
-78
-146
-136
-170
-179
-184
-265
EBITDA
-10
-25
-32
-77
-145
-135
-168
-174
-168
-238
Interest Expense
-
-
-
-
-
-
100
5
13
20
Depreciation
-
-
0
0
0
0
1
1
1
1
Income Before Tax
-11
-25
-33
-74
-140
-133
-69
-181
-184
-260
Income Tax Expense
-
-
1
4
-6
-3
-1
1
0
0
Net Income
-11
-25
-33
-74
-134
-130
-68
-181
-184
-260
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-373505.71%
-2156.21%
-766.22%
-238.52%
-200.27%

Rhythm Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-46
-44
-41
-141
-32
-43
-43
-49
-46
Operating Cash Flow
-41
-29
-29
-40
-29
-25
-18
-40
-23
Investing Cash Flow
48
-94
22
30
-8
-90
21
24
54
Financing Cash Flow
0
73
2
4
146
2
38
32
0
Change in Cash
6
-51
-4
-6
108
-113
41
16
29

Rhythm Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-25
-33
-74
-140
-133
-69
-181
-184
-260
Operating Cash Flow
-23
-29
-62
-122
-121
-146
-173
-136
-113
Investing Cash Flow
-5
-110
-87
-27
158
-62
28
-5
-48
Financing Cash Flow
-
167
164
163
2
166
213
74
191
Change in Cash
-28
27
15
12
38
-41
68
-67
29

Global Institutional Holdings in Rhythm Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
10.34%
RA Capital Management, LLC
9.18%
PRIMECAP Management Company
8.73%
Baker Bros Advisors LP
8.46%
Vanguard Group Inc
5.2%

Insights on Rhythm Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RYTM stock has moved up by 53.0%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -49.49M → -46.63M (in $), with an average increase of 6.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RYTM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RYTM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 32.70M → 48.50M (in $), with an average increase of 32.6% per quarter

About Rhythm Pharmaceuticals Inc

rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
OrganisationRhythm Pharmaceuticals Inc
Headquarters222 Berkeley Street, Boston, MA, United States, 02116
IndustryHealth Technology
CEODr. David P. Meeker M.D.
E-voting on sharesClick here to vote

Key Management of Rhythm Pharmaceuticals Inc

Name

Title

Mr. David Connolly

Head of Investor Relations & Corporate Communications

Dr. David P. Meeker M.D.

Chairman, President & CEO

Mr. Hunter C. Smith M.B.A.

CFO & Treasurer

Mr. Joseph Shulman

Chief Technical Officer

Mr. Yann Mazabraud

Executive VP & Head of International

Ms. Sarah Ryan

Vice President of Sales & Marketing

Ms. Jennifer Lee

Executive VP & Head of North America

Mr. Christopher P. German

Corporate Controller & Principal Accounting Officer

Dr. Alastair Garfield Ph.D.

Chief Scientific Officer

Mr. Jim Flaherty

Senior VP & General Counsel

FAQs

What is Rhythm Pharmaceuticals Inc share price today?

Rhythm Pharmaceuticals Inc share price today is $96.01 as on at the close of the market. Rhythm Pharmaceuticals Inc share today touched a day high of $97.05 and a low of $94.39.

What is the 52 week high and 52 week low for Rhythm Pharmaceuticals Inc share?

Rhythm Pharmaceuticals Inc share touched a 52 week high of $106.52 on and a 52 week low of $45.91 on . Rhythm Pharmaceuticals Inc stock price today i.e. is closed at $96.01,which is 9.87% down from its 52 week high and 109.15% up from its 52 week low.

What is Rhythm Pharmaceuticals Inc's market capitalisation today?

Rhythm Pharmaceuticals Inc market capitalisation is $0.01T as on .

How to invest in Rhythm Pharmaceuticals Inc Stock (RYTM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rhythm Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rhythm Pharmaceuticals Inc Shares that will get you 0.0156 shares as per Rhythm Pharmaceuticals Inc share price of $96.01 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rhythm Pharmaceuticals Inc Stock (RYTM) from India?

Indian investors can start investing in Rhythm Pharmaceuticals Inc (RYTM) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Rhythm Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Rhythm Pharmaceuticals Inc share’s latest price of $96.01 as on September 16, 2025 at 1:29 am IST, you will get 0.1042 shares of Rhythm Pharmaceuticals Inc. Learn more about fractional shares .